| |
| HEALTHCARE |
Vifor Pharma announces outcome of AFFIRM-AHF topline data
September 24, 2020
- The study narrowly missed statistical significance on the primary endpoint
- Pre-specified adjustment of COVID-19 impact, the study showed a statistically significant advantage
- The totality of evidence suggests that Ferinject® is clinically beneficial in high risk heart failure patients
Regulatory News: Vifor Pharma today announced topline data from its AFFIRM-AHF study evaluating the effect of Ferinject®"...
QFFD & QC ink $556,567 deal to enhance Sudan’s health system
September 22, 2020
THE Qatar Fund for Development (QFFD) and Qatar Charity (QC) have signed a cooperation agreement to implement projects aimed at strengthening health system emergency preparedness in Sudan. The projects, valued at $556,567, are expected to benefit some 2,452,800 people in the states of Kassala and the White Nile.
The deal was signed by Deputy Director-General of Development Projects at QFFD Mesfer bin Nasser Al Shahwani and Assistant CEO for the International Operations and Partnerships Sector at Qatar Charity Faisal"...
Takeda Presents New Data Highlighting Scientific Advancements in Lung Cancer at ESMO Virtual Congress
September 20, 2020
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the company is presenting data from its lung cancer portfolio at the virtual European Society for Medical Oncology (ESMO) conference. Notably, insights from sub-analyses of the Phase 3 ALTA 1L study reinforce both the compelling evidence of intracranial efficacy with ALUNBRIG® (brigatinib) as a first-line treatment for patients with anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) as well as associated quality of life (QoL) data. Takeda is also featuring updated 10-month follow-up results from the Phase 1/2 trial of mobocertinib (TAK-788), demonstrating mobocertinib achieved a duration of response (DoR) of more than one year in the trial’s study population of patients with epidermal growth factor receptor (EGFR) Exon20 insertion+ metastatic NSCLC (mNSCLC). “We’re pleased to present our ongoing research in lung cancer at this year’s virtual ESMO congress, including new results from our ongoing Phase 3 ALTA 1L......
COVID-19 lockdown lifted in Sudan
September 20, 2020
Sudan’s High Committee for Health Emergencies is to lift the COVID-19 lockdown in the country, however the State of Health Emergency will be maintained. In a statement on Wednesday, the High Committee pointed to the importance of observing the necessary health measures and adhering to the directives issued by the Ministry of Health to limit the transmission of the virus in the country, “as the COVID-19 pandemic has not disappeared yet”. "...
Patient recruitment starts for the international PRO-SID study evaluating Panzyga® for primary prophylaxis in patients with chronic lymphocytic leukaemia and secondary immunodeficiency
September 18, 2020
Octapharma is pleased to announce that the first site for the international PRO-SID (Primary Infection Prophylaxis with Panzyga® in Secondary Immunodeficiency in Chronic Lymphocytic Leukaemia) study was initiated in Milan, Italy, and patient recruitment is underway. Additional sites across Europe (Italy, Poland, Denmark, Hungary, Germany and Russia) and the USA are expected to begin recruitment soon. PRO-SID is the first randomised, placebo-controlled study to systematically evaluate the efficacy and safety of IVIG for"...
Vifor Pharma Group Announces Successful Sale of OM Pharma
September 18, 2020
- Vifor Pharma to sell 100% of OM Pharma to Optimus Holding Ltd. for a consideration of MCHF 435
- In addition Vifor Pharma obtains an earn out related to potential future value gains on 20% of Optimus Holding Ltd. equity which could increase the total transaction value in excess of MCHF 500
- Closure of the transaction is expected within 30 days
- Divestment strengthens Vifor Pharma’s focus on becoming the global leader in iron deficiency, nephrology and cardio-renal therapies
Regulatory"...
WHO Affirms Support to Sudan to face impacts of Floods
September 17, 2020
Khartoum, Sep. 16 (SUNA) - The Permanent Representative of Sudan in Geneva, Ambassador Ali bin Abi Talib, met today with the Director-General of the World Health Organization, Dr. Tadros Ghebreyesus, at the organization's headquarters in Geneva. The meeting discussed developments of health situation in Sudan, the impact of torrents and floods, which caused loss of lives, properties, and the damage of the infrastructure in vast areas in Sudan. "...
BOEHRINGER INGELHEIM AND MIRATI THERAPEUTICS ANNOUNCE CLINICAL COLLABORATION TO STUDY BI 1701963, A SOS1::PAN-KRAS INHIBITOR IN COMBINATION WITH MRTX849, A KRAS G12C SELECTIVE INHIBITOR
September 17, 2020
- First clinical study to evaluate novel combination blocking KRAS G12C and its activator SOS1 to potentially increase the therapeutic benefit for lung and colorectal cancer patients
- Study is based on preclinical evidence suggesting synergistic effect of KRAS G12C and SOS1 inhibition
Boehringer Ingelheim and Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced a clinical collaboration to evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor blocking KRAS independent of mutation"...
Sir Richard Branson Joins Dr. Anthony Fauci and Dr. Sanjay Gupta as Keynote Speakers for Everbridge’s Virtual Symposium, COVID-19: Road to Recovery (R2R), October 14-15, 2020
September 16, 2020
Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced the addition of premier keynotes and other business, healthcare and government executive speakers for its Autumn 2020 “COVID-19 R2R: The Road to Recovery” virtual leadership summit to be held October 14-15, 2020, covering the path forward amid the COVID-19 pandemic. Virgin Group Founder Sir Richard Branson joins presidential advisor and Director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health (NIH) Dr. Anthony Fauci and renowned neurosurgeon and CNN Chief Medical Correspondent Dr. Sanjay Gupta as keynote speakers. Additional speakers, including a world leader, will be announced at a later date. To register for this leadership event, please visit Everbridge’s event registration page. Everbridge’s two-day event will feature C-level speakers from many of the world’s leading organizations including Accenture, Aviva, Capital One, the CDC Foundation, Fortinet, Houston Methodist......
Sharjah Ladies Club Promotes Healthy Living, by Celebrating World Wellness Weekend
September 16, 2020
With World Wellness Weekend due to be celebrated on the 19th and 20th of September, Sharjah Ladies Club announced that they will be participating in the event for the second time with a range of both physical and virtual activities. Sharjah Ladies Club aims to bring women towards one goal by empowering and inspiring them to lead a healthier lifestyle, as well as providing opportunities to develop their skills and relax in world-class facilities while taking all safety precautions. Now"...
|
|
|
|
|